Jason Luke, MD, FACP
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center immunologist Jason Luke, MD, FACP, has been presented with the Sy Holzer Endowed Immunotherapy Research Fund Award to advance innovative research in cancer immunotherapy. Dr. Luke, a medical oncologist and clinical investigator, specializes in early-phase drug development for melanoma and solid tumors, serving as lead investigator for numerous immunotherapies over the past several years.
Dr. Luke is Director of the newly established Cancer Immunotherapeutics Center within the UPMC Cancer Immunology and Immunotherapy Program, and he has oversight of all early-phase immunotherapy studies. He received his medical degree from Rosalind Franklin University of Medicine and Science/Chicago Medical School and completed his internship and residency at Boston University Medical Center, followed by fellowships at Weill Cornell Medical College and Memorial Sloan Kettering Cancer Center, New York.
Dr. Luke has received multiple awards for research and clinical care, including the National Cancer Institute’s Cancer Clinical Investigator Team Leadership Award; the Melanoma Research Foundation Humanitarian Award; the ASCO Merit Award; as well as Young Investigator Awards from the Melanoma Research Alliance, the Cancer Research Foundation, and the Conquer Cancer Foundation of ASCO.
The Holzer Fund, now in its second year, was established to honor Mr. Holzer’s philanthropic work as the long-time President of PNC and his many years of service as Chair of UPMC Hillman Cancer Center Council.